Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: A biomarker evaluation from the AVAGAST randomized phase III trial
10.1200/JCO.2011.39.9824
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Other Authors: | |
| Format: | Article |
| Published: |
2014
|
| Online Access: | http://scholarbank.nus.edu.sg/handle/10635/116937 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Institution: | National University of Singapore |
| id |
sg-nus-scholar.10635-116937 |
|---|---|
| record_format |
dspace |
| spelling |
sg-nus-scholar.10635-1169372023-10-29T20:46:35Z Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: A biomarker evaluation from the AVAGAST randomized phase III trial Van Cutsem, E. De Haas, S. Kang, Y.-K. Ohtsu, A. Tebbutt, N.C. Xu, J.M. Yong, W.P. Langer, B. Delmar, P. Scherer, S.J. Shah, M.A. CANCER SCIENCE INSTITUTE OF SINGAPORE 10.1200/JCO.2011.39.9824 Journal of Clinical Oncology 30 17 2119-2127 JCOND 2014-12-12T07:59:26Z 2014-12-12T07:59:26Z 2012-06-10 Article Van Cutsem, E., De Haas, S., Kang, Y.-K., Ohtsu, A., Tebbutt, N.C., Xu, J.M., Yong, W.P., Langer, B., Delmar, P., Scherer, S.J., Shah, M.A. (2012-06-10). Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: A biomarker evaluation from the AVAGAST randomized phase III trial. Journal of Clinical Oncology 30 (17) : 2119-2127. ScholarBank@NUS Repository. https://doi.org/10.1200/JCO.2011.39.9824 0732183X http://scholarbank.nus.edu.sg/handle/10635/116937 000305159200018 Scopus |
| institution |
National University of Singapore |
| building |
NUS Library |
| continent |
Asia |
| country |
Singapore Singapore |
| content_provider |
NUS Library |
| collection |
ScholarBank@NUS |
| description |
10.1200/JCO.2011.39.9824 |
| author2 |
CANCER SCIENCE INSTITUTE OF SINGAPORE |
| author_facet |
CANCER SCIENCE INSTITUTE OF SINGAPORE Van Cutsem, E. De Haas, S. Kang, Y.-K. Ohtsu, A. Tebbutt, N.C. Xu, J.M. Yong, W.P. Langer, B. Delmar, P. Scherer, S.J. Shah, M.A. |
| format |
Article |
| author |
Van Cutsem, E. De Haas, S. Kang, Y.-K. Ohtsu, A. Tebbutt, N.C. Xu, J.M. Yong, W.P. Langer, B. Delmar, P. Scherer, S.J. Shah, M.A. |
| spellingShingle |
Van Cutsem, E. De Haas, S. Kang, Y.-K. Ohtsu, A. Tebbutt, N.C. Xu, J.M. Yong, W.P. Langer, B. Delmar, P. Scherer, S.J. Shah, M.A. Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: A biomarker evaluation from the AVAGAST randomized phase III trial |
| author_sort |
Van Cutsem, E. |
| title |
Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: A biomarker evaluation from the AVAGAST randomized phase III trial |
| title_short |
Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: A biomarker evaluation from the AVAGAST randomized phase III trial |
| title_full |
Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: A biomarker evaluation from the AVAGAST randomized phase III trial |
| title_fullStr |
Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: A biomarker evaluation from the AVAGAST randomized phase III trial |
| title_full_unstemmed |
Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: A biomarker evaluation from the AVAGAST randomized phase III trial |
| title_sort |
bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: a biomarker evaluation from the avagast randomized phase iii trial |
| publishDate |
2014 |
| url |
http://scholarbank.nus.edu.sg/handle/10635/116937 |
| _version_ |
1781789567828885504 |